ProShares Ultra Health Care
19 hedge funds and large institutions have $9.91M invested in ProShares Ultra Health Care in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
1% more capital invested
Capital invested by funds: $9.78M → $9.91M (+$133K)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
2.08% less ownership
Funds ownership: 22.41% → 20.33% (-2.1%)
5% less funds holding
Funds holding: 20 → 19 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $246K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.03M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$709K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$490K |
| 4 |
CIAS
Capital Investment Advisory Services
Raleigh,
North Carolina
|
+$156K |
| 5 |
MCC
Money Concepts Capital
Palm Beach Gardens,
Florida
|
+$60.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
-$2.39M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$861K |
| 3 |
Jane Street
New York
|
-$700K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$451K |
| 5 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$285K |
RXL Hedge Fund Activity: Q4 2022 in Review
19 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q4 2022, worth a combined $9.91M — up 1.4% from $9.78M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RXL and 5 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.
The largest buyer was Osaic Holdings, adding an estimated $2.03M. The largest seller was IMC Chicago, exiting entirely with an estimated $2.39M sold.
- 19 institutional investors held ProShares Ultra Health Care (RXL) as of Q4 2022, down from 20 in Q3 2022.
- Funds reported $9.91M of ProShares Ultra Health Care stock for Q4 2022, up 1.4% quarter-over-quarter.
- 5 funds opened new ProShares Ultra Health Care positions in Q4 2022 and 6 closed out, a net change of -1 holder.
- The largest ProShares Ultra Health Care buyer in Q4 2022 was Osaic Holdings, an estimated $2.03M added.
- The largest ProShares Ultra Health Care seller in Q4 2022 was IMC Chicago, an estimated $2.39M sold.
Based on aggregated 13F filings for Q4 2022.